Navigation Links
IDEV Technologies Names Christopher M. Owens President, Chief Executive Officer
Date:11/17/2009

HOUSTON, Nov. 17 /PRNewswire/ -- IDEV Technologies, Incorporated (IDEV), an emerging leader in the development and marketing of minimally invasive medical technologies, today announced it has named Christopher M. Owens its President and Chief Executive Officer, effective immediately.

"Chris has a proven track record of results-based leadership and is the right person to take the Company to the next level," said Board Chairman Rick Anderson. "Chris has a clear vision and strategy of how we will advance IDEV through an explosive growth phase. We are confident and proud to have Chris leading the organization."

Mr. Owens has nearly 20 years of medical device experience holding senior-level executive positions in both the commercial and technical areas. Prior to coming to IDEV, he was Vice President of Worldwide Marketing for MicroVention from 2005-2008, a start-up medical device company that was purchased by Terumo Corporation. From 2003-2005, he was Vice President, Global Research and Development for the Surgical Division of Bausch & Lomb. Mr. Owens earned a bachelor's degree and a master's degree in Plastics Engineering from the University of Massachusetts, Lowell, and an MBA from the University of Phoenix.

The Company also appointed veteran medical device executive William W. Burke to Executive Vice President and Chief Financial Officer. Mr. Burke has more than 25 years of medical technology experience as a board member, senior executive and acquisition and financing advisor. He currently serves on the board of directors of Medical Action Industries, Inc. and Aperio Technologies, Inc. From 2004 through 2007, he was Executive Vice President and Chief Financial Officer of ReAble Therapeutics, Inc. From 2001 to 2004, he served as Chief Financial Officer of Cholestech Corporation. Most recently, he served as President of Emergent Technologies, Inc. He earned a BBA in finance from the University of Texas at Austin and an MBA from The Wharton Graduate Business School at the University of Pennsylvania.

"Bill's extensive experience and capabilities as a CFO and healthcare executive will enable IDEV to accelerate our growth strategy," Mr. Anderson said. "We believe that Chris and Bill provide IDEV with an impressive combination of senior executive leadership, skills and experience. Under the leadership of these talented individuals, we look forward to a prosperous future."

"I believe we are building a strong foundation for growth and expansion for the treatment of biliary and peripheral artery disease," Mr. Owens said. "We have a robust technology portfolio and we will be expanding and leveraging our technologies into other markets, where it makes sense to do so."

In anticipation of future growth, IDEV has recently moved into an expanded, world-class facility in Webster, TX, Mr. Owens added.

About IDEV Technologies, Incorporated

IDEV Technologies, Incorporated (IDEV) is an innovator and developer of next generation medical devices for use in the interventional radiology, vascular surgery and cardiology device marketplace. IDEV worldwide headquarters is located in Webster, Texas with the European headquarters in Beuningen, Netherlands.

    Contact:  Julie Nguyen, Marketing Communications Manager
              IDEV Technologies, Incorporated
              (281) 525-2000

SOURCE IDEV Technologies, Incorporated


'/>"/>
SOURCE IDEV Technologies, Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
3. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
4. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
5. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
6. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
7. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
8. Senesco Technologies Initiates Preclinical Studies for Cancer Target
9. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
10. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
11. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):